menu search

NSTG / Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?
The mean of analysts' price targets for NanoString (NSTG) points to an 116.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. Read More
Posted: Apr 6 2022, 11:17
Author Name: Zacks Investment Research
Views: 110660

NSTG News  

Short squeeze alert for October 18th: 2 stocks that could soar

By Finbold
October 18, 2023

Short squeeze alert for October 18th: 2 stocks that could soar

In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their p more_horizontal

NanoString (NSTG) Advances in Xenotransplantation With New Study

By Zacks Investment Research
August 23, 2023

NanoString (NSTG) Advances in Xenotransplantation With New Study

NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through more_horizontal

NanoString Technologies, Inc. (NSTG) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 3, 2023

NanoString Technologies, Inc. (NSTG) Q2 2023 Earnings Call Transcript

NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Doug Farrell - Vice Presi more_horizontal

Why Shares of NanoString Technologies Are Falling Thursday

By The Motley Fool
May 18, 2023

Why Shares of NanoString Technologies Are Falling Thursday

NanoString Technologies may have to stop selling certain instruments and reagents in Germany. The company said it plans to appeal the ruling. more_horizontal

NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference

By Business Wire
March 1, 2023

NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational resear more_horizontal

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
February 28, 2023

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hol more_horizontal

NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference

By Business Wire
December 22, 2022

NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference

SEATTLE--( BUSINESS WIRE )--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational rese more_horizontal

NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript

By Seeking Alpha
August 6, 2022

NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript

NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Doug Farrell - Vice Presi more_horizontal


Search within

Pages Search Results: